Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 4
1993 2
1994 5
1995 3
1996 3
1997 4
1998 4
1999 5
2000 8
2001 8
2002 28
2003 34
2004 43
2005 78
2006 105
2007 125
2008 152
2009 176
2010 222
2011 240
2012 334
2013 319
2014 306
2015 266
2016 301
2017 284
2018 279
2019 252
2020 236
2021 236
2022 177
2023 179
2024 65

Text availability

Article attribute

Article type

Publication date

Search Results

3,941 results

Results by year

Filters applied: . Clear all
Page 1
Exenatide implant therapy in diabetes.
Kalra S, Saboo B. Kalra S, et al. J Pak Med Assoc. 2018 Oct;68(10):1538-1540. J Pak Med Assoc. 2018. PMID: 30317359 Review.
ITCA 650 is an implantable device which delivers sustained and stable concentrations of the glucagon-like peptide 1 receptor agonist exenatide, when inserted subcutaneously. The article discusses the pharmacodynamics and pharmacokinetics of ITCA 650, and suggests how it's …
ITCA 650 is an implantable device which delivers sustained and stable concentrations of the glucagon-like peptide 1 receptor agonist exen …
The Effectiveness and Safety of Exenatide Versus Metformin in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Ye ZR, Yan CQ, Liao N, Wen SH. Ye ZR, et al. Reprod Sci. 2023 Aug;30(8):2349-2361. doi: 10.1007/s43032-023-01222-y. Epub 2023 Mar 31. Reprod Sci. 2023. PMID: 37002532 Free PMC article. Review.
The purpose of this meta-analysis was to evaluate the reproductive efficacy and safety of exenatide, a glucagon-like peptide-1 receptor agonist, versus metformin, an insulin sensitizer, in the treatment of patients with PCOS. ...More high-quality studies are needed to asse …
The purpose of this meta-analysis was to evaluate the reproductive efficacy and safety of exenatide, a glucagon-like peptide-1 recept …
Exenatide ER-induced eosinophilia.
Eid TJ, Kaur M, Kaur R. Eid TJ, et al. Am J Health Syst Pharm. 2020 Jun 23;77(13):1006-1007. doi: 10.1093/ajhp/zxaa105. Am J Health Syst Pharm. 2020. PMID: 32470112 No abstract available.
Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice.
Xu Q, Zhang X, Li T, Shao S. Xu Q, et al. Mol Med. 2022 Dec 3;28(1):144. doi: 10.1186/s10020-022-00574-6. Mol Med. 2022. PMID: 36463128 Free PMC article.
Increased Th17 and decreased Treg cells in peripheral blood were present as diabetes progressed while exenatide corrected this imbalance. Progressive IL-17 + T cell infiltration of pancreatic islets was alleviated by exenatide intervention. ...In addition, PA could …
Increased Th17 and decreased Treg cells in peripheral blood were present as diabetes progressed while exenatide corrected this imbala …
Exenatide improves hypogonadism and attenuates inflammation in diabetic mice by modulating gut microbiota.
Chen Y, Shu A, Jiang M, Jiang J, Du Q, Chen T, Shaw C, Chai W, Chao T, Li X, Wu Q, Gao C. Chen Y, et al. Int Immunopharmacol. 2023 Jul;120:110339. doi: 10.1016/j.intimp.2023.110339. Epub 2023 May 19. Int Immunopharmacol. 2023. PMID: 37210914
With the rising incidence of diabetes and its onset at a younger age, the impact on the male reproductive system has gradually gained attention. Exenatide is a glucagon-like peptide-1 receptor agonist effective in the treatment of diabetes. ...Furthermore, exenatide …
With the rising incidence of diabetes and its onset at a younger age, the impact on the male reproductive system has gradually gained attent …
Exenatide-induced granulomatous panniculitis associated with poly(d,l-lactide-co-glycolide).
Zhu CS, Kwan EA, Williams GM, Lewin-Smith M, Lincoln MS, Lee AJ. Zhu CS, et al. J Cutan Pathol. 2022 May;49(5):496-499. doi: 10.1111/cup.14193. Epub 2022 Jan 6. J Cutan Pathol. 2022. PMID: 34954842
The extended-release formulation of exenatide for treatment of Type II diabetes mellitus is encapsulated in microspheres composed of poly(d,l-lactide-co-glycolide) (PLGA) and administered weekly. ...Of note, the lesions appeared following exenatide injections in the …
The extended-release formulation of exenatide for treatment of Type II diabetes mellitus is encapsulated in microspheres composed of …
The efficacy and safety of exenatide once weekly in patients with type 2 diabetes.
Heimbürger SM, Brønden A, Johansen NJ, Dejgaard TF, Vilsbøll T, Knop FK. Heimbürger SM, et al. Expert Opin Pharmacother. 2019 Apr;20(5):501-510. doi: 10.1080/14656566.2019.1571040. Epub 2019 Feb 7. Expert Opin Pharmacother. 2019. PMID: 30730773 Review.
In addition, the authors provide an outline of the novel formulations and delivery methods of exenatide. Expert opinion: Exenatide QW is an efficacious and safe treatment for T2D. ...In addition, exenatide QW appears inferior to liraglutide and semaglutide in …
In addition, the authors provide an outline of the novel formulations and delivery methods of exenatide. Expert opinion: Exenatide …
Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway.
Liu Y, Wang DW, Wang D, Duan BH, Kuang HY. Liu Y, et al. Front Endocrinol (Lausanne). 2021 Apr 19;12:663039. doi: 10.3389/fendo.2021.663039. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33953700 Free PMC article.
Exenatide (20 g/kg/day, subcutaneous) and specific exenatide inhibitors (20 g/kg/day, intraperitoneal) were used to determine the effects of exenatide on NASH. RESULTS: Exenatide treatment inhibited the pyroptosis signaling pathway to attenuate NASH. . …
Exenatide (20 g/kg/day, subcutaneous) and specific exenatide inhibitors (20 g/kg/day, intraperitoneal) were used to determine …
Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study.
van der Aart-van der Beek AB, Apperloo E, Jongs N, Rouw DB, Sjöström CD, Friedli I, Johansson L, van Raalte DH, Hoogenberg K, Heerspink HJL. van der Aart-van der Beek AB, et al. Diabetes Obes Metab. 2023 Jun;25(6):1758-1768. doi: 10.1111/dom.15033. Epub 2023 Mar 13. Diabetes Obes Metab. 2023. PMID: 36843215 Clinical Trial.
AIM: To evaluate the albuminuria-lowering effect of dapagliflozin, exenatide, and the combination of dapagliflozin and exenatide in patients with type 2 diabetes and microalbuminuria or macroalbuminuria. ...CONCLUSIONS: In participants with type 2 diabetes and album …
AIM: To evaluate the albuminuria-lowering effect of dapagliflozin, exenatide, and the combination of dapagliflozin and exenatide …
Exenatide inhibits NF-kappaB and attenuates ER stress in diabetic cardiomyocyte models.
Fu Z, Mui D, Zhu H, Zhang Y. Fu Z, et al. Aging (Albany NY). 2020 May 11;12(9):8640-8651. doi: 10.18632/aging.103181. Epub 2020 May 11. Aging (Albany NY). 2020. PMID: 32392536 Free PMC article.
Exenatide is used to treat patients with type-2 diabetes and it also exerts cardioprotective effects. ...Notably, re-activation of the NF-kappaB signaling pathway abolished Exenatide's protective effects on hyperglycemic cardiomyocytes. Taken together, our re …
Exenatide is used to treat patients with type-2 diabetes and it also exerts cardioprotective effects. ...Notably, re-activation of th …
3,941 results

Searches related to "exenatide"